日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation

早期非小细胞肺癌（NSCLC）围手术期帕博利珠单抗治疗：肿瘤微环境和外周循环的常规及基于分布的免疫分析

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-012432
Zhang, Jingxuan; Lin, Lin; Enzor, Jennifer H; Patel, Prekshaben H; Steadman, Katelyn N; Little, Victoria E; Gu, Lin; Oduah, Eziafa I; Tong, Betty C; Antonia, Scott J; Ready, Neal E; Weinhold, Kent J
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2025
文献求助 收藏

cytoGPNet: Enhancing clinical outcome prediction accuracy using longitudinal cytometry data in small cohort studies

cytoGPNet：利用小型队列研究中的纵向细胞计数数据提高临床结果预测准确性

期刊:Patterns
影响因子:7.4
doi:10.1016/j.patter.2025.101297
Zhang, Jingxuan; Sun, Liwen; Ready, Neal E; Guo, Wenbo; Lin, Lin
细胞生物学
发表日期：2025
文献求助 收藏

Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment

接受三线治疗的广泛期小细胞肺癌患者的真实世界疗效、生存结果和治疗模式

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70289
Bar, Jair; Xu, Qingqing; Karve, Sudeep; Hingorani, Pooja; Virani, Amin A; Ready, Neal E
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

cytoGPNet: Enhancing Clinical Outcome Prediction Accuracy Using Longitudinal Cytometry Data in Small Cohort Studies

cytoGPNet：利用小型队列研究中的纵向细胞计量数据提高临床结果预测准确性

期刊:
影响因子:
doi:10.1101/2025.05.01.651729
Zhang, Jingxuan; Sun, Liwen; Ready, Neal E; Guo, Wenbo; Lin, Lin
细胞生物学
发表日期：2025
文献求助 收藏

First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817

一线纳武利尤单抗联合伊匹木单抗治疗转移性非小细胞肺癌，包括ECOG体能状态评分为2的患者和其他特殊人群：CheckMate 817

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006127
Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, Osvaldo; Curioni Fontecedro, Alessandra; Sánchez-Gastaldo, Amparo; Juan-Vidal, Oscar; Linardou, Helena; Poddubskaya, Elena; Spigel, David R; Ahmed, Samreen; Maio, Michele; Li, Sunney; Chang, Han; Fiore, Joseph; Acevedo, Angelic; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial

一项针对未经治疗的转移性非小细胞肺癌患者的纳武利尤单抗、伊匹木单抗和紫杉醇联合治疗的 II 期临床试验：OPTIMAL 试验

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100337
Clarke, Jeffrey M; Gu, Lin; Wang, Xiaofei F; Stinchcombe, Thomas E; Stevenson, Marvaretta M; Ramalingam, Sundhar; Shariff, Afreen; Garst, Jennifer; Nixon, Andrew B; Antonia, Scott J; Crawford, Jeffrey; Ready, Neal E
肺癌
肿瘤
肿瘤免疫
TIM
细胞生物学
发表日期：2022
文献求助 收藏

Challenges associated with the integration of immuno-oncology agents in clinical practice

将免疫肿瘤药物整合到临床实践中面临的挑战

期刊:BMC Medical Education
影响因子:3.2
doi:10.1186/s12909-022-03847-0
Lazure, Patrice; Parikh, Aparna R; Ready, Neal E; Davies, Marianne J; Péloquin, Sophie; Caterino, Jeffrey M; Lewandowski, Robert; Lazar, Alexander J; Murray, Suzanne
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer

早期免疫疗法与颅外放射疗法在转移性非小细胞肺癌中的协同作用

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-20-537
Chodavadia, Parth A; Jacobs, Corbin D; Wang, Frances; Salama, Joseph K; Kelsey, Chris R; Clarke, Jeffrey M; Ready, Neal E; Torok, Jordan A
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness

不可手术的IIB期非小细胞肺癌的根治性放射治疗：治疗模式和疗效比较

期刊:Clinical Lung Cancer
影响因子:3.3
doi:10.1016/j.cllc.2019.10.005
Jacobs, Corbin D; Gao, Junheng; Wang, Xiaofei; Clarke, Jeffrey M; Tong, Betty; Ready, Neal E; Suneja, Gita; Kelsey, Chris R; Torok, Jordan A
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial

Durvalumab联合或不联合Tremelimumab治疗PD-L1低表达/阴性复发或转移性头颈部鳞状细胞癌患者的安全性和有效性：CONDOR II期随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2018.4628
Siu, Lillian L; Even, Caroline; Mesía, Ricard; Remenar, Eva; Daste, Amaury; Delord, Jean-Pierre; Krauss, Jürgen; Saba, Nabil F; Nabell, Lisle; Ready, Neal E; Braña, Irene; Kotecki, Nuria; Zandberg, Dan P; Gilbert, Jill; Mehanna, Hisham; Bonomi, Marcelo; Jarkowski, Anthony; Melillo, Giovanni; Armstrong, Jon M; Wildsmith, Sophie; Fayette, Jérôme
PD-L1
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏